Medical Health & Life Science Research News

New study: In vivo toxicology market worth 6.14 billion USD by 2022

Medical Market Research

[196 Pages Report] In Vivo Toxicology Market report categorizes the global market by Testing type (Chronic, Sub-chronic), Testing Facility (Outsourced, In-house), Product (Instruments, Consumables (Animal models, Reagents & Kits)), Toxicity Endpoints (Immunotoxicity, Systemic, DART) & Geography

- Advertising -

Browse 124 tables and 38 figures spread through 196 pages and in-depth TOC on "In Vivo Toxicology Market"

www.marketsandmarkets.com/Market-R…et-105308811.html

Early buyers will receive 10% customization on this report 

The consumables segment is expected to hold the largest share of the market 

Based on product, the In Vivo Toxicology Market is segmented into consumables and instruments. The consumables segment is further divided into reagents & kits and animal models.

In 2017, the consumables segment is expected to account for the largest share of the In Vivo Toxicology Market owing to the increasing R&D funding for the development of new transgenic animal models, advancements in the development of genetically modified animals, increasing usage of reagents and kits for biological sample analysis.

By testing type, sub-acute toxicity testing to register the highest CAGR during the forecast period 

Inquiry Report @ www.marketsandmarkets.com/Enquiry_…mpaign=prnewswire

The In Vivo Toxicology Market is segmented by testing type into chronic, sub-chronic, sub-acute, and acute toxicology testing.

- Advertising -

In 2017, the sub-acute toxicity testing segment is expected to register the highest CAGR of during the forecast period. Growth in this market is attributed to the increasing focus on neurological and anti-viral drug research, which requires more than two weeks of toxicity studies.

The US is expected to dominate the In Vivo Toxicology Market in 2017 

In 2017, the US is estimated to account for the largest share of the In Vivo Toxicology Market, followed by Germany and the UK. However, China is expected to grow at the highest CAGR during the forecast period.

Factors such as rising R&D funding and collaborations; initiatives by the Chinese government to promote life science research; and the strong trend of commercialization of biotechnology research are contributing to the growth of the In Vivo Toxicology Market in China.

Download PDF Brochure@ www.marketsandmarkets.com/pdfdownload.asp?id=105308811

The major players in the global In Vivo Toxicology Market include Thermo Fisher (US), Danaher (US), Charles River (US), Covance (LabCorp), and The Jackson Laboratory (US).

News From

MarketsandMarkets™ - Business ResearchMarketsandMarkets™
Category: Market Research Publishers and RetailersCompany about: MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions. Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth ...
This email address is being protected from spambots. You need JavaScript enabled to view it.